Lastly, we observed elevated numbers of infiltrating CD4+ CTLs in pre-anti-PD-1 treatment biopsies of metastatic melanoma patients, suggesting that CD4 T-cells may contribute actively to an anti-tumor response. This evidence concerns the gene CD4 and neoplasm.